Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
17.58 USD | -3.67% |
|
-3.67% | +24.59% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company returns high margins, thereby supporting business profitability.
- The company is in a robust financial situation considering its net cash and margin position.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 52.97 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+24.59% | 11.29B | - | ||
-5.30% | 181B | C+ | ||
-5.19% | 100B | C | ||
-5.73% | 65.01B | A | ||
+16.45% | 45.75B | B+ | ||
-8.02% | 44.8B | B- | ||
+8.48% | 43.72B | B- | ||
+13.02% | 29.01B | B | ||
+17.98% | 26.03B | A- | ||
-6.69% | 24.28B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- FPH Stock
- FSPKF Stock
- Ratings Fisher & Paykel Healthcare Corporation Limited